
EuroPCR 2027
A European interventional cardiovascular medicine course covering coronary, valvular and imaging topics for hospital teams, physicians and cardiovascular device companies.
EuroPCR is an international course and congress for interventional cardiovascular medicine, held in Paris and organising academic exchange, case learning and clinical education around core directions including coronary intervention, valvular disease treatment, heart failure, peripheral intervention, hypertension, stroke intervention and cardiovascular imaging.
Congress themes cover STEMI, left main and multivessel disease in coronary intervention; TAVI, mitral valve replacement and repair and other valvular and structural interventions; acute heart failure; below-the-knee disease in peripheral intervention; and hypertension-related renal artery angioplasty and stroke-related carotid artery stenting.
Beyond the themed sessions, the congress includes courses and certification pathways such as the PCR London Valves course, PCR Innovators Day, the PCR Global Interventional Academy, a pre-course on cardiogenic shock and an advanced course on transseptal puncture, with pre- and post-congress learning resources including cases, course slides and videos.
The event connects interventional cardiology experts, imaging professionals, nursing and related medical communities and supports continuous learning through the EuroIntervention journal, the PCR Textbook and the heart failure care community iHF. The previous edition attracted 106 exhibiting companies and 12,147 participants, with about 500 sessions arranged alongside.
Area
Exhibitors
Visitors
EuroPCR 2027 takes place from 18 to 21 May 2027.
EuroPCR 2027 takes place in Paris, France, at the Palais des Congrès de Paris.
EuroPCR 2027 marks 50 years of coronary angioplasty and is held under the theme 'Learning from the Past. Shaping the Future.'
EuroPCR is the world-leading course in interventional cardiovascular medicine.

EuroPCR 2027
A European interventional cardiovascular medicine course covering coronary, valvular and imaging topics for hospital teams, physicians and cardiovascular device companies.
EuroPCR is an international course and congress for interventional cardiovascular medicine, held in Paris and organising academic exchange, case learning and clinical education around core directions including coronary intervention, valvular disease treatment, heart failure, peripheral intervention, hypertension, stroke intervention and cardiovascular imaging.
Congress themes cover STEMI, left main and multivessel disease in coronary intervention; TAVI, mitral valve replacement and repair and other valvular and structural interventions; acute heart failure; below-the-knee disease in peripheral intervention; and hypertension-related renal artery angioplasty and stroke-related carotid artery stenting.
Beyond the themed sessions, the congress includes courses and certification pathways such as the PCR London Valves course, PCR Innovators Day, the PCR Global Interventional Academy, a pre-course on cardiogenic shock and an advanced course on transseptal puncture, with pre- and post-congress learning resources including cases, course slides and videos.
The event connects interventional cardiology experts, imaging professionals, nursing and related medical communities and supports continuous learning through the EuroIntervention journal, the PCR Textbook and the heart failure care community iHF. The previous edition attracted 106 exhibiting companies and 12,147 participants, with about 500 sessions arranged alongside.
Area
Exhibitors
Visitors
EuroPCR 2027 takes place from 18 to 21 May 2027.
EuroPCR 2027 takes place in Paris, France, at the Palais des Congrès de Paris.
EuroPCR 2027 marks 50 years of coronary angioplasty and is held under the theme 'Learning from the Past. Shaping the Future.'
EuroPCR is the world-leading course in interventional cardiovascular medicine.